Smartwatch study aims to track cancer fatigue

NCT ID NCT06291324

Recruiting now Knowledge-focused Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This pilot study is testing whether wearable activity trackers, like fitness watches, can help monitor fatigue in people with pancreatic or breast cancer who are undergoing treatment. Researchers want to see if patients will use the device daily and find it easy to use. The study involves 46 participants and lasts 14 days, focusing on whether this approach is practical for future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: wearable activity tracker device
What this could lead to: If successful, this could show that wearable devices are a practical way to track fatigue in cancer patients, leading to better symptom management.
What could go wrong: This is a very small pilot study with only 46 participants, so results may not apply to all patients. It focuses on feasibility, not on proving the device reduces fatigue.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Fatigue invasive breast carcinoma malignant pancreatic neoplasm pancreatic neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER PANCREATIC CANCER

Contacts and locations

Locations

Levine Cancer Institute
RECRUITING

Charlotte, North Carolina, 28204, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.